Literature DB >> 31759150

Transcirculation Approach for Endovascular Embolization of Intracranial Aneurysms, Arteriovenous Malformations, and Dural Fistulas: A Multicenter Study.

Jorge A Roa1, Santiago Ortega-Gutierrez2, Mario Martinez-Galdamez3, Alberto Maud4, Guilherme Dabus5, Avery Pazour6, Sudeepta Dandapat6, Miguel Schüller Arteaga3, Jorge Galvan Fernandez3, Diego Paez-Granda7, Vladimir Kalousek8, Roger Barranco Pons9, Ashkan Mowla10, Gary Duckwiler10, Viktor Szeder10, Pascal Jabbour11, David M Hasan12, Edgar A Samaniego13.   

Abstract

BACKGROUND: Unfavorable anatomy can preclude traditional anterograde endovascular interventions. Transcirculation approaches, which consist of primary catheterization of a target artery from the contralateral side or opposite cerebral circulation, can provide alternative pathways for successful treatment of these patients. We aimed to assess the safety, efficacy, and outcomes of endovascular embolization through transcirculation approaches.
METHODS: Nine centers provided retrospective data on patients who underwent transcirculation procedures for embolization of intracranial aneurysms (IAs), dural arteriovenous fistulas (dAVFs), and arteriovenous malformations (AVMs). Raymond-Roy Occlusion Classification (RROC) grades and degree of obliteration were used to evaluate treatment success. Minor/major complications and clinical/angiographic outcomes were also assessed. A review of the literature reporting patients who underwent transcirculation embolizations was also performed.
RESULTS: Forty patients were included in the study (34 IAs, 3 AVMs, and 3 dAVFs). Most IAs (22/34, 64.7%) were treated electively. Three AVMs and 2 dAVFs presented ruptured. RROC grade I-II was achieved in 97% of IAs. All AVMs and dAVFs were completely obliterated. One patient developed a transient arterial thrombus that was successfully treated with intravenous tirofiban. The most common indications for a transcirculation approach were difficult access angle of the target lesion (42.5%) and occlusion of the parent artery (27.5%). The review of the literature pooled 152 IAs treated via transcirculation approaches. Most common locations were the basilar tip (27%), posterior inferior cerebellar artery (25%), and internal carotid artery (15.1%). The posterior communicating artery was crossed in 60 (39.5%), anterior communicating artery in 48 (31.6%), and vertebral artery in 37 (24.3%) patients. Primary coiling alone was performed in 22 (14.5%), stent-assisted coiling in 67 (44.1%), balloon-assisted coiling in 36 (23.7%), stent-assisted coiling + balloon-assisted coiling in 20 (13.2%) and flow diversion in 7 (4.6%) patients. After intervention, 142 (93.4%) IAs achieved successful RROC grades I-II. Two major complications (1.3%) leading to death were reported, both of which were intraprocedural aneurysmal ruptures with massive subarachnoid hemorrhage and herniation. After a mean angiographic follow-up of 11.3 months, only 6/108 (5.6%) IAs showed intrasaccular filling/recurrence.
CONCLUSIONS: Transcirculation approaches seem to be safe and effective in the treatment of IAs, dAVFs, and AVMs. The most common indication for a transcirculation approach is the presence of a difficult angle to access the target lesion and occlusion of the parent artery.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endovascular device; Endovascular embolization; Endovascular intervention; Intracranial aneurysm; Neurointerventional technique; Transcirculation approach

Mesh:

Year:  2019        PMID: 31759150     DOI: 10.1016/j.wneu.2019.11.078

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Transcirculation Approach for Mechanical Thrombectomy in Acute Ischemic Stroke: A Multicenter Study and Review of the Literature.

Authors:  Jorge A Roa; Alberto Maud; Pascal Jabbour; Guilherme Dabus; Avery Pazour; Sudeepta Dandapat; Santiago Ortega-Gutierrez; Diego Paez-Granda; Vladimir Kalousek; David M Hasan; Edgar A Samaniego
Journal:  Front Neurol       Date:  2020-05-07       Impact factor: 4.003

2.  Transcirculation microballoon-assisted coil embolization for dorsal pancreatic artery aneurysm due to celiac artery dissection: A case report.

Authors:  Yuki Takara; Daisuke Yunaiyama; Toru Saguchi; Natsuhiko Shirota; Takafumi Yamada; Junetsu Akasaka; Kazuhiro Saito
Journal:  SAGE Open Med Case Rep       Date:  2021-01-09

3.  Stent-assisted Coil Embolization Using a Transcirculation Technique for Superior Cerebellar Artery Aneurysm: A Report of Two Cases.

Authors:  Kokyo Sakurada; Akio Teranishi; Eisuke Tsukagoshi; Satoshi Iihoshi; Hiroki Kurita; Shinya Kohyama
Journal:  NMC Case Rep J       Date:  2022-04-01

4.  Vertebral artery transection with pseudoaneurysm and arteriovenous fistula requiring antegrade and retrograde embolization.

Authors:  Maham Karatela; E Hope Weissler; Mitchell W Cox; Zachary F Williams
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-03-03

5.  Study on the Effect of Hope Theory Combined with Psychological Intervention on the Improvement of Prognosis.

Authors:  Tingting Zou; Jing Liu; Liping Tan
Journal:  Contrast Media Mol Imaging       Date:  2022-09-26       Impact factor: 3.009

6.  Transcirculation Silk Vista Baby-assisted coiling in half-T configuration for the treatment of posterior communicating artery aneurysms associated with a fetal posterior circulation: An alternative flow diversion strategy.

Authors:  Mario Martínez-Galdámez; Miguel Schüller-Arteaga; Jorge Galván-Fernández; Vladimir Kalousek; Ezequiel Petra; Boris Pabón; Santiago Ortega-Gutiérrez; Paloma Jiménez-Arribas; Carlos Rodríguez-Arias
Journal:  Interv Neuroradiol       Date:  2020-09-23       Impact factor: 1.610

7.  Long-term outcomes of brainstem arteriovenous malformations after different management modalities: a single-centre experience.

Authors:  Yu Chen; Ruinan Li; Li Ma; Xiangyu Meng; Debin Yan; Hao Wang; Xun Ye; Hengwei Jin; Youxiang Li; Dezhi Gao; Shibin Sun; Ali Liu; Shuo Wang; Xiaolin Chen; Yuanli Zhao
Journal:  Stroke Vasc Neurol       Date:  2020-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.